{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:49:03Z","timestamp":1783482543443,"version":"3.55.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>\n                                 <jats:italic toggle=\"yes\">Clostridium difficile<\/jats:italic>-associated diarrhea (CDAD) remains a persistent challenge, with substantially increased incidence and severity. The rising burden of CDAD requires urgent identification of preventable risk factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients concerns:<\/jats:title>\n            <jats:p>A 77-year-old man with the symptoms of abdominal pain and watery diarrhea was readmitted to the hospital, who received cephalosporins and proton pump inhibitors (PPIs) during the initial hospitalization for 12 days until discharge. Antibiotic-associated diarrhea was seriously suspected. And the stool sample was immediately sent for inspection for <jats:italic toggle=\"yes\">C difficile<\/jats:italic>. He had a history of chronic bronchitis, coronary heart disease, and osteonecrosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>CDAD, renal insufficiency<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Oral vancomycin was administered for 14 days.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>On the third day after readmission, the stool sample turned out to be positive for both <jats:italic toggle=\"yes\">C difficile<\/jats:italic> toxin and its antigen. After 10-day treatment with vancomycin, diarrhea symptoms disappeared and his stools became normal.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>In elderly patients with multiple comorbidities, PPIs must be administered cautiously to minimize the risk for adverse effects including CDAD. It is important to identify the preventable risk factors of CDAD for clinicians and pharmacists. Oral vancomycin therapy seems to be effective in CDAD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000015004","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T18:57:14Z","timestamp":1553799434000},"page":"e15004","source":"Crossref","is-referenced-by-count":10,"title":["Clostridium difficile-associated diarrhea following the therapy with antibiotic and proton pump inhibitors in a 77-year-old man with several comorbidities"],"prefix":"10.1097","volume":"98","author":[{"given":"Xiaoqun","family":"Lv","sequence":"first","affiliation":[{"name":"Department of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Jinshan Hospital, Fudan University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifang","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghong","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMra1403772","article-title":"Clostridium difficile infection","volume":"372","author":"Leffler","year":"2015","journal-title":"N Engl J Med"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2169\/internalmedicine.52.0162","article-title":"Clostridium difficile infection associated with antituberculous agents in a patient with tuberculous pericarditis","volume":"52","author":"Sun","year":"2013","journal-title":"Intern Med"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"e0176797","DOI":"10.1371\/journal.pone.0176797","article-title":"The emergence of Clostridium difficile infection in Asia: a systematic review and meta-analysis of incidence and impact","volume":"12","author":"Borren","year":"2017","journal-title":"PLoS One"},{"key":"R4-20230914","first-page":"749789","article-title":"Lethal Clostridium difficile colitis associated with paclitaxel and carboplatin chemotherapy in ovarian carcinoma: case report and review of the literature","author":"Masciullo","year":"2010","journal-title":"Obstet Gynecol Int"},{"key":"R5-20230914","first-page":"207","article-title":"Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage \u2013 two case reports with review of the changing epidemiology of Clostridium","volume":"66","author":"Bauer","year":"2008","journal-title":"Neth J Med"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/PPA.S150388","article-title":"The impact of pharmaceutical interventions on the rational use of proton pump inhibitors in a Chinese hospital","volume":"12","author":"Xin","year":"2017","journal-title":"Patient Prefer Adherence"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/2042098617715381","article-title":"Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence","volume":"8","author":"Maes","year":"2017","journal-title":"Ther Adv Drug Saf"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jac\/dkr508","article-title":"Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics","volume":"67","author":"Hensgens","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa051639","article-title":"A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality","volume":"353","author":"Loo","year":"2005","journal-title":"N Engl J Med"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1017\/ice.2016.2","article-title":"Inappropriate antibiotic use and gastric acid suppression preceding Clostridium difficile infection","volume":"37","author":"Croft","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jhin.2017.08.017","article-title":"Updated meta-analysis of controlled observational studies: proton-pump inhibitors and risk of Clostridium difficile infection","volume":"98","author":"Cao","year":"2018","journal-title":"J Hosp Infect"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.3748\/wjg.v23.i35.6500","article-title":"Proton pump inhibitors therapy and risk of Clostridium difficile infection: systematic review and meta-analysis","volume":"23","author":"Trifan","year":"2017","journal-title":"World J Gastroenterol"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1111\/1462-2920.12285","article-title":"Gastric microbiota is altered in oesophagitis and Barrett's oesophagus and further modified by proton pump inhibitors","volume":"16","author":"Amir","year":"2014","journal-title":"Environ Microbiol"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"e9089","DOI":"10.1097\/MD.0000000000009089","article-title":"When omeprazole met with asymptomatic Clostridium difficile colonization in a postoperative colon cancer patient: a case report","volume":"96","author":"Li","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/519265","article-title":"A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile\u2013associated diarrhea, stratified by disease severity","volume":"45","author":"Zar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/jama.2009.171","article-title":"A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection","volume":"301","author":"Kelly","year":"2009","journal-title":"JAMA"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201903290-00044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T20:25:38Z","timestamp":1694723138000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201903290-00044"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":16,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000015004","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}